Neurophysiological Biomarkers of Parkinson’s Disease

BACKGROUND: There is a need for reliable and robust Parkinson’s disease biomarkers that reflect severity and are sensitive to disease modifying investigational therapeutics. OBJECTIVE: To demonstrate the utility of EEG as a reliable, quantitative biomarker with potential as a pharmacodynamic endpoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Waninger, Shani, Berka, Chris, Stevanovic Karic, Marija, Korszen, Stephanie, Mozley, P. David, Henchcliffe, Claire, Kang, Yeona, Hesterman, Jacob, Mangoubi, Tomer, Verma, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242849/
https://www.ncbi.nlm.nih.gov/pubmed/32116262
http://dx.doi.org/10.3233/JPD-191844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242849/
https://www.ncbi.nlm.nih.gov/pubmed/32116262
http://dx.doi.org/10.3233/JPD-191844

Ejemplares similares